PMDA inspection

Novo Nordisk (China) Pharmaceuticals Co., Ltd. Tianjin Plant

PMDA inspection 5130608002573 · China · Suitable

Key facts

Control number 5130608002573
Manufacturing site Novo Nordisk (China) Pharmaceuticals Co., Ltd. Tianjin Plant
Location No.99, Nanhai Road, TEDA, Tianjin, P.R.China 300457
Country China
Product type Pharmaceuticals
Application type Complete Change
Inspection method Remote
Inspection month May 1, 2024
Result Suitable
Result notified Jun 4, 2024
PMDA registration AG10500738

About PMDA GMP inspections (Japan)

Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.

Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan

Browse all PMDA GMP inspections (Japan)